Our Research

The Study Behind

the Mission

Our Research

The Research Behind the Mission

Explore the research that drives our

innovative approach to Lyme disease treatment.

Discover the research driving our innovative approach to

Lyme disease treatment.

The Technology

We are exploring the use of electromagnetic (EM) energy as a direct treatment for Borrelia burgdorferi, the bacteria that causes Lyme disease. While lab-based (in vitro) studies have shown that EM energy can effectively target bacteria, it has not yet been used in human patients for this purpose. Recent laboratory research also suggests that EM treatments may help break down bacterial biofilm, which is often linked to persistent Lyme symptoms.

In our study, we are using this promising technology to evaluate its potential therapeutic effects in individuals with persistent Lyme-related symptoms.

Lyme Treatment Research

A Prospective Study of Patients with Post Treatment Lyme Disease Syndrome

Treated with Variable Frequency Electromagnetic Energy (VFEM)

Gregory P. Derderian DO, Nicole Otenbaker RN, BSN

A Prospective Study of Patients with

Post Treatment Lyme Disease Syndrome Treated with Variable Frequency Electromagnetic Energy (VFEM)

Gregory P. Derderian DO,

Nicole Otenbaker RN, BSN

Abstract:

Background: We previously demonstrated a possible therapeutic benefit of variable frequency electromagnetic energy technology for the treatment of Post Treatment Lyme Disease Syndrome (PTLDS) or Chronic Lyme Disease (CLD). As a result, we prospectively enrolled 10 patients, all having significant debility, to determine to what extent we could improve their quality of life. Eight patients completed the 10 treatments. Results: All eight patients had a significant improvement in quality of life within a 4-month time frame. Conclusion: VFEM is a stand-alone modality that appears to demonstrate a significant improvement in quality of life in PTLDS or CLD with little or no risk or side effects of treatment.

Background

Lyme disease is often a devastating illness, leaving many patients debilitated, unable to work or maintain reasonable daily activities. It can affect both physical and emotional states of well-being. Lyme patients often experience financial difficulties without the benefit of resolution of their symptoms with much of their treatments costs not covered by insurance. PTLDS and CLD are difficult to treat not only due to the ability of Borrelia to produce biofilm, but also having multiple morphologies thus resisting current treatments (1). Another factor appears to be the slow replication rate of Borrelia, and its predilection for tissues not rich in blood supply which makes it more difficult for the immune system to respond to (2). In the search for an affordable, dependable treatment for Lyme disease we are exploring the optimal therapeutic use of electromagnetic energy. A search of the literature yielded isolated in vitro research using magnetic fields for its direct antibacterial effects or potentiation of antibiotic therapy (3,4,5,6,7,8,9,10,11,12,1). Earlier this year we reported on five patients treated with VFEM for Post Treatment Lyme Disease Syndrome (PTLDS) or Chronic Lyme Disease (CLD)(12). The number of treatments varied as well as the interval between treatments, ranging from days to months, due to patient location. All five patients had functional improvement after treatment.

Kickstart your Healing Journey with Lyme Rescue

Kickstart your

Healing Journey with Lyme Rescue

Connect with us to setup a complimentary consultation if you feel you could be a candidate for this innovative treatment.

Join the Fight Against Lyme Disease

Your support directly funds treatment access, patient support, and groundbreaking research.

538 N Old Woodward Ave, Birmingham, MI 48009

P.O. Box 338 Birmingham, MI 48012

Quick Links

Home

About Us

Our Research

Success Stories

Board

Contact Us

FAQs

Stay Connected

©2025 Lyme Rescue Corporation 501(c)(3). All Rights Reserved. Privacy Policy.

©2025 Lyme Rescue Corporation 501(c)(3).

All Rights Reserved. Privacy Policy.